India Non Invasive Prenatal Testing Market Size & Outlook

The non invasive prenatal testing market in India is expected to reach a projected revenue of US$ 242.4 million by 2030. A compound annual growth rate of 14% is expected of India non invasive prenatal testing market from 2023 to 2030.
Revenue, 2022 (US$M)
$85.0
Forecast, 2030 (US$M)
$242.4
CAGR, 2023 - 2030
14%
Report Coverage
India

India non invasive prenatal testing market, 2018-2030 (US$M)

India

Related Markets

India non invasive prenatal testing market highlights

  • The India non invasive prenatal testing market generated a revenue of USD 85.0 million in 2022 and is expected to reach USD 242.4 million by 2030.
  • The India market is expected to grow at a CAGR of 14% from 2023 to 2030.
  • In terms of segment, 13-24 weeks was the largest revenue generating gestation period in 2022.
  • 0-12 weeks is the most lucrative gestation period segment registering the fastest growth during the forecast period.


Non invasive prenatal testing market data book summary

Market revenue in 2022USD 85.0 million
Market revenue in 2030USD 242.4 million
Growth rate14% (CAGR from 2022 to 2030)
Largest segment13-24 weeks
Fastest growing segment0-12 weeks
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentation0-12 weeks, 13-24 weeks, 25-36 weeks
Key market players worldwideCooperSurgical, Natera Inc, Eurofins Scientific SE, Illumina Inc, Centogene NV Ordinary Shares, MedGenome, Myriad Genetics Inc, Roche Holding AG, Qiagen NV, Labcorp Holdings Inc, Quest Diagnostics Inc, Biora Therapeutics


Other key industry trends

  • In terms of revenue, India accounted for 2.2% of the global non invasive prenatal testing market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China non invasive prenatal testing market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 242.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Non Invasive Prenatal Testing Market Companies

Name Profile # Employees HQ Website

India non invasive prenatal testing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non invasive prenatal testing market will help companies and investors design strategic landscapes.


13-24 weeks was the largest segment with a revenue share of 52% in 2022. Horizon Databook has segmented the India non invasive prenatal testing market based on 0-12 weeks, 13-24 weeks, 25-36 weeks covering the revenue growth of each sub-segment from 2018 to 2030.


In India, NIPT is allowed to be utilized only to detect genetic disorders in embryos, such as sickle cell anemia, cystic fibrosis, phenylketonuria, and thalassemia. NIPT procedures are carried out only at registered genetic clinics and by a registered & qualified person under the Pre-Conception and Prenatal Diagnostic Due to the high prices of NIPT, doctors sent the samples abroad for examination.

This was happening owing to the lack of labs in the country, but now some labs in India have initiated examination of NIPT tests within the country. Improvements in healthcare facilities in the country are likely to drive the market over the forecast period.

In March 2021, Bio serve Biotechnology launched NIPT services in the country. Under the PRENITA brand, the company provides diagnostic testing for prenatal and postnatal patients, advanced preimplantation genetic screening/diagnosis, and carrier screening services.

Reasons to subscribe to India non invasive prenatal testing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of India non invasive prenatal testing market databook

  • Our clientele includes a mix of non invasive prenatal testing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the India non invasive prenatal testing market , including forecasts for subscribers. This country databook contains high-level insights into India non invasive prenatal testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

India non invasive prenatal testing market size, by gestation period, 2018-2030 (US$M)

India Non Invasive Prenatal Testing Market Outlook Share, 2022 & 2030 (US$M)

India non invasive prenatal testing market size, by gestation period, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more